Keyphrases
Childhood Acute Lymphoblastic Leukemia
100%
Drug Sensitivity
100%
Doxorubicin
100%
Etoposide
100%
ETV6-RUNX1
100%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
60%
Cytarabine
40%
Gene Fusion
40%
Amsacrine
40%
No Significant Difference
20%
Tumor Cells
20%
Prednisolone
20%
Patient Characteristics
20%
Cyclophosphamide
20%
Cellular Mechanisms
20%
High Hyperdiploidy
20%
Cell Sensitivity
20%
Drug Resistance
20%
High-throughput Methods
20%
6-Thioguanine (6-TG)
20%
Cytotoxicity Assay
20%
Fluorometric
20%
TEL-AML1
20%
RUNX1 Gene
20%
Microculture
20%
Hydroperoxy
20%
Neuroscience
In Vitro
100%
RUNX1
100%
ETV6
100%
Doxorubicin
100%
Etoposide
100%
Dexamethasone
40%
Cytarabine
40%
Gene Fusion
40%
Amsacrine
40%
Prednisolone
20%
Cyclophosphamide
20%
Drug Resistance
20%
Vincristine
20%
Tioguanine
20%
Cytotoxicity Assay
20%
Biochemistry, Genetics and Molecular Biology
ETV6
100%
RUNX1
100%
Drug Sensitivity
100%
Doxorubicin
100%
Precursor
60%
Cytarabine
40%
Dexamethasone
40%
Gene Fusion
40%
Amsacrine
40%
Prednisolone
20%
Drug Resistance
20%
Cyclophosphamide
20%
Cytotoxicity Assay
20%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Acute Lymphoblastic Leukemia
100%
Etoposide
100%
Dexamethasone
50%
Cytarabine
50%
Amsacrine
50%
Neoplasm
25%
Prednisolone
25%
Tioguanine
25%
Drug Resistance
25%
Vincristine
25%
Perfosfamide
25%
Cytotoxicity Assay
25%